Can Long-Term Antidepressant Use Be Depressogenic?
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Article AbstractLetter to the EditorSir: We appreciated the thoughtful review on the loss of antidepressant efficacy by Byrne and Rothschild. We would like to put forward another possible explanation for the observation: long-term antidepressant use may be depressogenic. While this idea seems counterintuitive, there are reasons to seriously consider it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A potential detrimental manifestation of long-term treatment with antidepressants may be the emotional blunting phenomenon (vide infra) or otherwise 'depressogenic' phenomena [33-36].”
From The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications (2019) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Serotonin-dopamine interaction and its relevance to schizophrenia
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.4.466 · Cited by 823
Antidepressant-induced mania and cycle acceleration: a controversy revisited
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1130 · Cited by 608
Rapid Cycling in Manic-Depressives Induced by Tricyclic Antidepressants
Wehr, T. A. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780050065007 · Cited by 408
BindingDB (2011) · PubMed · doi:10.7270/q2cr5rw8 · Cited by 333
Anderson, I. M. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)7:1+<1::aid-da1>3.3.co;2-j · Cited by 278
Safety of mirtazapine: a review
Montgomery, S. A. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199512004-00006 · Cited by 214
Feiger, A. D., Kiev, A., Shrivastava, R. K., Wisselink, P., & Wilcox, C. S. (1996) · PubMed · Cited by 185
Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline*
Modell, J. G., Katholi, C. R., Modell, J. D., & DePalma, R. L. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90198-3 · Cited by 183
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.10.1514 · Cited by 168
Emergence of obsessive compulsive symptoms during treatment with clozapine.
Baker, R. W., Kn, C., Baird, J. W., Steingard, S., Christ, M. A., & Nr, S. (1992) · PubMed · Cited by 156
Research works printed but not linked: 22
- Harrison WM, Rabkin JG, Ehrhardt AA, et al. Effects of antidepres- sant medication on sexual function: a controlled study. J Clin Psycho- pharmacol 1986;6:144-149
- Patterson WM. Fluoxetine-induced sexual dysfunction [letter]. J Clin Psychiatry 1993;54:71
- Balogh S, Hendricks SE, Kang J. Treatment of fluoxetine-induced anorgasmia with amantadine [letter]. J Clin Psychiatry 1992;53: 212-213
- Andrade C. Risperidone may worsen fluoxetine-treated OCD [letter with reply]. J Clin Psychiatry 1998;59:255-256
- Saxena S, Bystritsky A. Reply to Andrade C: Risperidone may worsen fluoxetine-treated OCD [letter]. J Clin Psychiatry 1998;59:256
- Alzaid K, Jones BD. Case report of risperidone-induced obsessive- compulsive symptoms [letter]. J Clin Psychopharmacol 1997;17: 58-59
- Mahendran R. Obsessional symptoms associated with risperidone treatment. Aust N Z J Psychiatry 1998;32:299-301 REFERENCES
- McDougle CJ, Goodman WK, Leckman JF, et al. Haloperidol addi- tion in fluvoxamine-refractory obsessive-compulsive disorder: a double-blind, placebo-controlled study in patients with and without tics. Arch Gen Psychiatry 1994;51:302-308
- Andrade C. Risperidone may worsen fluoxetine-treated OCD [letter with reply]. J Clin Psychiatry 1998;59:255-256
- Andrade C. Risperidone may worsen fluoxetine-treated OCD [letter]. J Clin Psychiatry 1998;59:255-256
- Saxena S, Bystritsky A. Reply to Andrade C: Risperidone may worsen fluoxetine-treated OCD [letter]. J Clin Psychiatry 1998;59: 256
- Cassady SL, Thaker GK. Addition of fluoxetine to clozapine [letter]. Am J Psychiatry 1992;149:1274
- Patil VJ. Development of transient obsessive-compulsive symptoms during treatment with clozapine [letter]. Am J Psychiatry 1992;149: 272
- Patel B, Tandon R. Development of obsessive-compulsive symptoms during clozapine treatment [letter]. Am J Psychiatry 1993;150:836
- Remington G, Adams, M. Risperidone and obsessive-compulsive symptoms [letter]. J Clin Psychopharmacol 1994;14:358-359
- Kopala L, Honer WG. Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia [letter]. Am J Psy- chiatry 1994;151:1714-1715 REFERENCES
- Byrne SE, Rothschild AJ. Loss of antidepressant efficacy during main- tenance therapy: possible mechanisms and treatments. J Clin Psychia- try 1998;59:279-288
- Baker MW, Croll RP. Modulation of in vivo neuronal sprouting by serotonin in the adult CNS of the snail. Cell Mol Neurobiol 1996;16: 561-576
- Meshul CK, Janowsky A, Casey DE, et al. Effect of haloperidol and clozapine on the density of "perforated" synapses in caudate, nucleus accumbens, and medial prefrontal cortex. Psychopharmacology (Berl) 1992;106:45-52
- Diefenbach TJ, Sloley BD, Goldberg JI. Neurite branch development of an identified serotonergic neuron from embryonic Helisoma: evi- dence for autoregulation by serotonin. Dev Biol 1995;167:282-293
- Scupi BS, Maser JD, Uhde TW. The National Institute of Mental Health Panic Questionnaire: an instrument for assessing clinical char- acteristics of panic disorder. J Nerv Ment Dis 1992;180:566-577
- Folinsbee LJ. Heat and air pollution. In: Pollock ML, Schmidt DH, eds. Heart Disease and Rehabilitation. 3rd ed. Champaign, Ill: Human Kinetics; 1995:327-335
Cited by
Can long-term treatment with antidepressant drugs worsen the course of depression?
Fava, G. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0204 · Cited by 223
Leykin, Y., Amsterdam, J. D., DeRubeis, R. J., Gallop, R., Shelton, R. C., & Hollon, S. D. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.2.267 · Cited by 82
Fornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
Tardive dysphoria: The role of long term antidepressant use in-inducing chronic depression
El‐Mallakh, R. S., Gao, Y., & Roberts, R. J. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.01.020 · Cited by 81
Self-citationAntidepressant-associated chronic irritable dysphoria (acid) in bipolar disorder: a case series
EI‐Mallakh, R. S., & Karippot, A. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.08.004 · Cited by 57
The antidepressant standoff: Why it continues and how to resolve it
Ormel, J., Spinhoven, P., de Vries, Y. A., Cramer, A. O. J., Siegle, G. J., Bockting, C. L. H., & Hollon, S. D. (2020) · Psychological Medicine · doi:10.1017/s0033291719003295 · Cited by 22
“Excess relapse/recurrence rates in the placebo-substitution arms compared to the cmADM arms are strongest in the first month after discontinuation and gradually drop to approximately zero in the next 3–6 months (Borges et al., 2014; El-Mallakh et al., 1999; Kaymaz et al., 2008).”
Chronic Depression in Bipolar Disorder
El‐Mallakh, R. S., & Karippot, A. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.8.1337 · Cited by 22
Self-citationWeinberger, A. H., Hitsman, B. L., Papandonatos, G. D., Sacco, K. A., Vessicchio, J. C., & George, T. P. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181bfd0b4 · Cited by 18
“All analyses were conducted using R.(7) Journal of Clinical Psychopharmacology & Volume 29, Number 6, December 2009 Letters to the Editors”
BackgroundMethodInfluentialAntidepressant-Induced Tardive Dysphoria
El-Mallakh, R. S., Gao, Y., Briscoe, B. T., & Roberts, R. J. (2011) · Psychotherapy and Psychosomatics · doi:10.1159/000316799 · Cited by 13
Self-citationDelayed Loss of Efficacy and Depressogenic Action of Antidepressants
Raja, M. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181c0e60b · Cited by 10
Antidepressant discontinuation in treatment resistant depression
Ali, Z. A., Nuss, S., & El‐Mallakh, R. S. (2019) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2019.100383 · Cited by 8
Self-citationA Novel Residents' Research Seminar
El‐Mallakh, R. S. (2001) · Academic Psychiatry · doi:10.1176/appi.ap.25.1.57 · Cited by 6
Self-citationTardive dysphoria: antidepressant-induced chronic depression
El‐Mallakh, R. S., Roberts, R. J., Swann, A. C., Rutherford, P. R., & Surja, A. (2011) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700011976 · Cited by 6
Self-citationHasler, F. (2023) · transcript Verlag eBooks · doi:10.14361/9783839445716 · Cited by 3
Metadata
- Authors
- El-Mallakh, R. S., Waltrip, C., & Peters, C.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-04-15
- Volume
- 60
- Issue
- 4
- Pages
- 263
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1989417083
- Cited by
- 14
- References
- 33
- Citations by year
- 2023: 1 · 2019: 2 · 2018: 1
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- long-term antidepressant use
- MeSH terms
- Antidepressive Agents, Depressive Disorder, Dose-Response Relationship, Drug, Drug Administration Schedule, Humans, Synaptic Transmission, Synapses, Tachyphylaxis, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.